Steve Kramer

Title: Steve Kramer: Innovator in Antibody-Enzyme Conjugates

Introduction

Steve Kramer is a notable inventor based in Middletown, DE (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for conjugating compounds. With a total of 2 patents, his work has implications for various applications in healthcare and diagnostics.

Latest Patents

One of Steve Kramer's latest patents is focused on the deactivation of linking moieties in antibody-enzyme conjugates. This invention pertains to a method for conjugating a first compound to a second compound, involving an electrophilic moiety. The method includes reacting the first compound with the second compound to form a conjugate. An improvement in this invention involves adding a nucleophilic reagent to the conjugate, which forms a neutral product upon reaction with unreacted electrophilic moieties. This approach ensures that the conjugate formed is doubly deactivated, enhancing its stability and effectiveness.

Career Highlights

Steve Kramer is currently employed at Siemens Healthcare Diagnostics GmbH, where he continues to innovate in the field of diagnostics. His work is characterized by a commitment to advancing medical technology and improving patient outcomes through innovative solutions.

Collaborations

Throughout his career, Steve has collaborated with notable colleagues, including Alan Robert Craig and Ashok Koul. These collaborations have contributed to the development of groundbreaking technologies in the healthcare sector.

Conclusion

Steve Kramer is a distinguished inventor whose work in antibody-enzyme conjugates has the potential to transform the field of diagnostics. His innovative methods and collaborations highlight his dedication to advancing healthcare technology.